Model
Edge
Phio Pharmaceuticals Corporation
PHIO
Filing Type
10-Q
Filing Date
8/13/2025
Updated
8/14/25, 2:48 PM
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q2
EX-10.2
FORM OF INDEMNIFICATION AGREEMENT.
EX-10.3
SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS, DATED AUGUST 11, 2025, BY AND BETWEEN THE COMPANY AND ROBERT INFARINATO.
EX-31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
EX-31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
EX-32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic